IMPAL.NS(IMPAL.NS)
IMPAL.NS
No analyst ratings available
No analyst price targets available for IMPAL.NS
Analyst coverage may not be available for this symbol
No recent analyst actions
| Metric | FY2027E | FY2028E | FY2029E | FY2030E |
|---|---|---|---|---|
| Revenue Avg | $5.50B | $5.89B | $5.44B | $6.04B |
| Low | $5.50B | $5.89B | $5.44B | $6.04B |
| High | $5.50B | $5.89B | $5.44B | $6.04B |
| EBITDA Avg | $379M | $401M | $597M | $670M |
| Low | $379M | $401M | $597M | $670M |
| High | $379M | $401M | $597M | $670M |
| EBIT Avg | $362M | $383M | $579M | $651M |
| Low | $362M | $383M | $579M | $651M |
| High | $362M | $383M | $579M | $651M |
| Net Income Avg | $294M | $311M | $470M | $528M |
| Low | $294M | $311M | $470M | $528M |
| High | $294M | $311M | $470M | $528M |
| EPS Avg | $23.55 | $24.88 | $37.63 | $42.29 |
| Low | $23.55 | $24.88 | $37.63 | $42.29 |
| High | $23.55 | $24.88 | $37.63 | $42.29 |
| Analysts (Rev / EPS) | 1 / 1 | 1 / 1 | 1 / 1 | 1 / 1 |